Logo

CRUK

Cancer Research UK, Abcam Partner to Develop Custom Antibodies for Cancer Research

Abcam will develop custom protein-based reagents for

AstraZeneca, ArcherDx Partner on Minimal Residual Disease Monitoring for Lung Cancer Drug Trials

ArcherDx will develop sequencing-based circulating tumor DNA assays for use in AstraZeneca's recently launched Phase III MERMAID-1 trial of durvalumab (Imfinzi).

Genetic Alterations in Breast Cancer Influence Tumor Ecosystems

Researchers combined imaging mass spectrometry and genomic data to identify the cell types present in more than 480 breast cancer samples.

New Early Cancer Detection Alliance to Trial Bevy of New Technologies and Tests
Premium

The number of technologies to be assessed is vast, and ranges from liquid biopsies and molecular imaging to immunohistochemistry and RNA-seq.

Lung Cancer Studies From TRACERx Consortium Explore How Tumor Cells Evolve

Researchers from the TRACERx consortium analyzed blood and tumor samples to tease out features of lung cancers that are more likely to recur.

Apr 22, 2019

Liquid Biopsy Utility Reinforced in Early Results From UK TARGET Program

Jan 23, 2019

Cancer Research UK Names Latest Grand Challenge Competition Winners

Dec 14, 2018

In Brief This Week: Cancer Research UK, NeoGenomics, Luminex, and More

Dec 11, 2018

In Race for Blood-Based Cancer Detection, More Teams Turn to Epigenetic, Fragment-Based Analysis
Premium

Nov 30, 2018

Liquid Biopsy Test to Guide Prostate Cancer Treatment Being Developed With £5M Award
Premium

Apr 18, 2018

AACR Business Roundup: Thermo Fisher, Mission Bio, Stand Up To Cancer, Cancer Research UK

Nov 1, 2017

Natera Joins UK Longitudinal Breast Cancer Liquid Biopsy Study

Aug 17, 2017

As Brexit Negotiations Unfold, UK Researchers and Institutions Remain Worried About Coming Changes
Premium

Apr 26, 2017

Lung Cancer Studies Yield Insight Into Tumor Evolution, Support Liquid Biopsy Potential

Apr 3, 2017

Cancer Researchers Detail Efforts to 'Discover, Predict, Prevent, Treat' at Opening of AACR Meeting

Mar 24, 2017

Cancer Research UK Invests £10M in Personalized Approach to Pancreatic Cancer

Dec 1, 2016

CRUK's Personalized Breast Cancer Program Aims to Develop Clinical Sequencing Framework
Premium

Jan 26, 2016

Inivata Raises £31.5M in Series A Financing Round

Nov 16, 2015

Exome, Targeted Sequencing of Biopsy, ctDNA Reveals Clonal Evolution of Breast Cancer Tumors
Premium

Oct 22, 2015

HSBC to Provide $25M to Support Francis Crick Institute

Oct 1, 2015

Meta-Analysis Links Five New Variants to Brain Cancer Risk

Sep 4, 2015

CRUK Reports Results of First Phase of Stratified Medicine Program as It Implements NGS Panel
Premium

Aug 21, 2015

CRUK Report Finds Cancer MDx Testing Lagging in UK

Jun 26, 2015

CRUK Designates Three Centers as Research Hubs with £15M in Funding

Apr 23, 2015

CRUK Manchester Institute Joins European Consortium Validating Blood-based Cancer Biomarkers

Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.